:

Homeland Security

Briefing

DDN

Wednesday, October 3rd, 2007

SHARE:

*Emergent BioSolutions [EBS] received a $400 million contract from the Department of Health and Human Services (HHS) to provide 18.75 million doses of the anthrax vaccine BioThrax through Sept. 2010 for the strategic national stockpile. Contract terms also include an additional $34 million if the Food and Drug Administration approves the company's pending supplement to its biologics license application to extend the shelf life of BioThrax from three years to four years. On top of all that, HHS will provide…

Missile Defense

Guetlein On Golden Dome: ‘We Cannot Protect This Nation And Bankrupt It At The Same Time’

While there has been criticism among missile defense advocates of Golden Dome’s development pace after the signing of an executive order in January last year, Space Force Gen. Michael Guetlein, […]

Missile Defense

Interview with Rep. Jeff Crank (R-Colo.), co-chair of the Golden Dome Caucus

Rep. Jeff Crank (R-Colo.), a co-chair of the Golden Dome Caucus in Congress and a member of the House Armed Services Committee’s strategic forces panel, discusses the transformative defense investments […]

Space

Space Force PAE For Infrastructure Completing Move To Colorado Springs

U.S. Space Force Space Systems Command’s (SSC) Portfolio Acquisition Executive (PAE) for infrastructure–a $4 billion contracting hub for SSC–is completing a move from Los Angeles Air Force Base, Calif. to […]

Congress

Wisconsin GOP Lawmakers Urge Trump Admin Support For Marines’ JLTV Second Supplier Effort

Wisconsin’s GOP congressional delegation is urging the Trump administration to support legislative language enabling the Marine Corps to potentially bring in a second Joint Light Tactical Vehicle (JLTV) supplier. The […]